Vadivel, K., Zaiss, A. K., Kumar, Y., Fabian, F. M., Ismail, A. E. A., Arbing, M. A., . . . Bajaj, S. P. (2020). Enhanced Antifibrinolytic Efficacy of a Plasmin-Specific Kunitz-Inhibitor (60-Residue Y11T/L17R with C-Terminal IEK) of Human Tissue Factor Pathway Inhibitor Type-2 Domain1. J Clin Med.
Citación estilo ChicagoVadivel, Kanagasabai, Anne K. Zaiss, Yogesh Kumar, Frank M. Fabian, Ayman E. A. Ismail, Mark A. Arbing, Wallace G. Buchholz, William H. Velander, and S. Paul Bajaj. "Enhanced Antifibrinolytic Efficacy of a Plasmin-Specific Kunitz-Inhibitor (60-Residue Y11T/L17R With C-Terminal IEK) of Human Tissue Factor Pathway Inhibitor Type-2 Domain1." J Clin Med 2020.
Cita MLAVadivel, Kanagasabai, et al. "Enhanced Antifibrinolytic Efficacy of a Plasmin-Specific Kunitz-Inhibitor (60-Residue Y11T/L17R With C-Terminal IEK) of Human Tissue Factor Pathway Inhibitor Type-2 Domain1." J Clin Med 2020.